Prothena Reports First Quarter Financial Results
14 mai 2013 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, May 14, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the...
First Patient Dosed in Phase I Study of Prothena's Therapeutic Antibody for Treatment of AL Amyloidosis
23 avr. 2013 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, April 23, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the...
Prothena Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Research and Development Update
28 mars 2013 16h05 HE
|
Prothena Corporation plc
Company Advances Pipeline With Strong Capital Position Following 2012 Spin-Off
NEOD001 to Enter Clinic in Early 2013
DUBLIN, Ireland, March 28, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc...
Prothena Announces Appointments of Chief Medical Officer and Chief Financial Officer
25 mars 2013 16h30 HE
|
Prothena Corporation plc
DUBLIN, Ireland, March 25, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena to Report Fourth Quarter and Full Year 2012 Financial Results and Host Webcast and Conference Call on March 28, 2013
21 mars 2013 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, March 21, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Achieves Orphan Drug Status in EU for Lead Program NEOD001
27 févr. 2013 16h30 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Feb. 27, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena to Ring NASDAQ Stock Market Opening Bell
13 févr. 2013 06h00 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Feb. 13, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Announces Addition of Industry Veterans to Board of Directors
07 janv. 2013 08h00 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Begins Trading on NASDAQ Global Market Under Symbol "PRTA"
21 déc. 2012 01h30 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...